Literature DB >> 378238

IgG antibodies to double-stranded DNA in systemic lupus erythematosus sera. Independent variation of complement fixing activity and total antibody content.

A Beaulieu, F P Quismorio, G J Friou, B Vayuvegula, G Mirick.   

Abstract

Antibodies to double-stranded deoxyribonucleic acid were studied using the kinetoplast of Crithidia luciliae. Titers were determined separately by conventional immunofluorescence and the complement fluorescent technique, and results by the two methods were compared. Complement fixing activity varied independently of antibody content in whole serum and in IgG fractions. The well established correlation of complement fixing activity of this antibody with activity of lupus nephritis appears related, therefore, to qualitative rather than solely quantitative differences. This finding has important implications for the clinical assessment of patients with lupus, and investigations on the relationship of anti-DNA antibodies to lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378238     DOI: 10.1002/art.1780220602

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  IgG subclass distribution in organ specific autoantibodies. The relationship to complement fixing ability.

Authors:  B M Dean; G F Bottazzo; A G Cudworth
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

2.  DNA antibodies with and without complement-binding ability.

Authors:  A M Teppo; P Kurki; T Helve; O Wegelius
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

Review 3.  Current perspectives on serological reactions in SLE patients.

Authors:  M Reichlin
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

Review 4.  Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease.

Authors:  R Smeenk; K Brinkman; H van den Brink; R M Termaat; J Berden; H Nossent; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 5.  Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE).

Authors:  T Swaak; R Smeenk
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

6.  Circulating DNA-antibodies in systemic lupus erythematosus.

Authors:  T Helve; A M Teppo; P Kurki; O Wegelius
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

7.  Measurement of anti-DNA antibodies: a reappraisal using five different methods.

Authors:  D A Isenberg; C Dudeney; W Williams; I Addison; S Charles; J Clarke; A Todd-Pokropek
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

8.  Complement fixation by anti-dsDNA antibodies in SLE: measurement by radioimmunoassay and relationship with disease activity.

Authors:  C G Mackworth-Young; J K Chan; C C Bunn; G R Hughes; A E Gharavi
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

9.  Immune complex signatures of patients with active and inactive SLE revealed by multiplex protein binding analysis on antigen microarrays.

Authors:  Krisztián Papp; Péter Végh; Renáta Hóbor; Zoltán Szittner; Zoltán Vokó; János Podani; László Czirják; József Prechl
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.